EUVIMEDEUVIMED entdecken
Crossref

The Novel HLA‐B*15:747 Allele Identified by Next‐Generation Sequencing

Wenqi Hu, Zhaoli Du

HLA · 2026-01 · 107 (1)

DOI: 10.1111/tan.70543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, online erschienen am 28.12.2025. Verfasst von Wenqi Hu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan,…. Hauptthemen laut MEDLINE: Exons, HLA-B15 Antigen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The novel allele HLA‐B*15:747 differs from HLA‐B*15:25:01:01 by one single nucleotide substitution at residue 403 (C>A) in exon 3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExonsHLA-B15 AntigenHumansAllelesBase SequenceHigh-Throughput Nucleotide SequencingHistocompatibility TestingPolymorphism, Single NucleotideSequence AlignmentSequence Analysis, DNA

Stichwörter der Autor:innen

HLA‐B*15:747HLAnext‐generation sequencingnovel allele

Substanzen

HLA-B15 Antigen

Autor:innen und Institutionen

  • Department of Health Management, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Shandong Engineering Research Center of Health Management, Jinan, China.
  • Yinfeng Gene Technology Co. Ltd., Jinan, China.

Zitieren

APA

Hu, W., & Du, Z. (2026). The Novel HLA‐B*15:747 Allele Identified by Next‐Generation Sequencing. HLA, 107(1). https://doi.org/10.1111/tan.70543

Vancouver

Hu W, Du Z. The Novel HLA‐B*15:747 Allele Identified by Next‐Generation Sequencing. HLA. 2026;107(1). doi:10.1111/tan.70543

BibTeX
@article{Hu2026,
  author = {Hu, Wenqi and Du, Zhaoli},
  title = {The Novel HLA‐B*15:747 Allele Identified by Next‐Generation Sequencing},
  journal = {HLA},
  year = {2026},
  volume = {107},
  number = {1},
  doi = {10.1111/tan.70543}
}
Kostenlos starten →